Funds holding GAIN THERAPEUTICS INC
ISIN US36269B1052 · United States
- Fund holders
- 9
- Of which ETFs
- 1 8 other funds
- Value held
- 1.9M $
- Share of capital
- 2.2 % of 43.6M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 430,902 | 874.7K $ | 0.00 % | 0.99 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 207,106 | 403.9K $ | 0.00 % | 0.47 % | as of May 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 144,159 | 292.6K $ | 0.02 % | 0.33 % | as of Jun 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 57,335 | 111.8K $ | 0.00 % | 0.13 % | as of May 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 55,636 | 108.5K $ | 0.00 % | 0.13 % | as of May 31, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 30,004 | 60.9K $ | 0.04 % | 0.07 % | as of Jun 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 28,629 | 55.8K $ | 0.00 % | 0.07 % | as of May 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 9,730 | 19.8K $ | 0.01 % | 0.02 % | as of Jun 30, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 966 | 2K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.04 % | as of Jun 30, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.02 % | as of Jun 30, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.01 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 9 | -2 | 964,467 | +13.1 % |
| 2026Q2 | 11 | +1 | 852,558 | +7.3 % |
| 2026Q1 | 10 | +2 | 794,499 | +12.2 % |
| 2025Q4 | 8 | 0 | 707,957 | -18.3 % |
| 2025Q3 | 8 | -1 | 866,193 | +59.1 % |
| 2025Q2 | 9 | 0 | 544,399 | +15.1 % |
| 2025Q1 | 9 | +1 | 472,947 | +36.9 % |
| 2024Q4 | 8 | -2 | 345,415 | -8.5 % |
| 2024Q3 | 10 | 0 | 377,371 | +15.0 % |
| 2024Q2 | 10 | -2 | 328,175 | +2.2 % |
| 2024Q1 | 12 | -4 | 321,200 | +9.7 % |
| 2023Q4 | 16 | 292,765 |
Institutional managers
39 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| MARSHALL WACE, LLP | 1,769,788 | 3.4M $ | as of Mar 31, 2026 |
| Potomac Capital Management, Inc. | 1,008,600 | 2M $ | as of Mar 31, 2026 |
| JONES FINANCIAL COMPANIES LLLP | 631,615 | 1.2M $ | as of Mar 31, 2026 |
| Cambridge Investment Research Advisors, Inc. | 568,645 | 1.1K $ | as of Mar 31, 2026 |
| DME Capital Management, LP | 566,130 | 1.1M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 447,342 | 868.5K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 431,267 | 836.7K $ | as of Mar 31, 2026 |
| GSA CAPITAL PARTNERS LLP | 312,467 | 606 $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 225,046 | 436.6K $ | as of Mar 31, 2026 |
| UBS Group AG | 220,489 | 427.7K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 216,883 | 420.8K $ | as of Mar 31, 2026 |
| Cresset Asset Management, LLC | 160,000 | 310.4K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 157,537 | 305.6K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 139,652 | 270.9K $ | as of Mar 31, 2026 |
| Stratos Wealth Partners, LTD. | 131,621 | 255.3K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 113,997 | 221.2K $ | as of Mar 31, 2026 |
| LPL Financial LLC | 104,251 | 202.2K $ | as of Mar 31, 2026 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 35,820 | 69.5K $ | as of Mar 31, 2026 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 30,004 | 58.2K $ | as of Mar 31, 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | 29,703 | 57.6K $ | as of Mar 31, 2026 |
| Apollon Wealth Management, LLC | 26,500 | 51.4K $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 24,900 | 48.3K $ | as of Mar 31, 2026 |
| Schonfeld Strategic Advisors LLC | 24,500 | 47.5K $ | as of Mar 31, 2026 |
| Oliver Luxxe Assets LLC | 20,250 | 39.3K $ | as of Mar 31, 2026 |
| Wealthspire Advisors, LLC | 16,900 | 32.8K $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding GAIN THERAPEUTICS INC". https://titelia.com/en/stocks/gain-therapeutics-inc-US36269B1052